EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combining imaging strategies with physiologically-based pharmacokinetic modeling to improve precision dosing & drug delivery in brain tumors

Tamara Jordens, Anne-Jaël Elskamp, Imke H Bartelink

Journal of Controlled Release · 2026-11 · 399 · 115451

DOI: 10.1016/j.jconrel.2026.115451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Tamara Jordens und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location VUmc, De Boelelaan 1117, Amsterdam, 1081 HV, the Netherlands; Cancer Center …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Brain Neoplasms, Drug Delivery Systems, Models, Biological. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small molecule targeted therapies frequently fail to control brain metastases and primary brain tumors even when systemic exposure reaches toxicity-limiting levels. Systemic exposure-response relationships are often absent, which is well documented for tyrosine kinase inhibitors. Target-site information is therefore needed, since the concentration reached in the tumor is determined not by plasma exposure, but by passive and active transport across the blood-brain barrier and by intratumoral heterogeneity. Physiologically-based pharmacokinetic (PBPK) modeling provides the mechanistic framework to describe this. Models built solely on in vitro-to-in vivo extrapolation of permeability and transport have repeatedly required correction factors derived from rodent data, and their evaluation in humans still depends on invasive sampling or microdialysis. Microdialysis performs poorly for lipophilic, highly protein-bound drugs. We argue that quantitative imaging can supply the missing in vivo input. In a hybrid strategy, in vitro-derived transport parameters serve as the starting point, while blood-brain barrier influx and efflux are recalibrated on positron emission tomography (PET) microdose measurements in patients. This could lead to improved prediction of brain concentrations at therapeutic doses and allows simulated target-site exposure to be weighed against in vitro potency for compound and dose selection. Beyond whole-brain averages, magnetic resonance imaging (MRI) can provide permeability and perfusion parameters longitudinally and in larger cohorts, whereas mass spectrometry imaging (MSI) techniques can map intratumoral heterogeneity in drug distribution in the tumor microenvironment and identify potential sanctuary sites. We map each modality onto the specific PBPK parameters it can inform, and argue that imaging-informed, spatially resolved PBPK is a realistic route toward model-informed precision dosing in neuro-oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBrain NeoplasmsDrug Delivery SystemsModels, BiologicalAnimalsHumansBlood-Brain BarrierPositron-Emission Tomography

Stichwörter der Autor:innen

Brain tumorsMacroscopic imagingMicroscopic imagingPhysiologically-based pharmacokineticsPrecision dosingTumor heterogeneity

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location VUmc, De Boelelaan 1117, Amsterdam, 1081 HV, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Van der Boechorststraat 6B, Amsterd…

Förderung

  • KWF Kankerbestrijding

Zitieren

APA

Jordens, T., Elskamp, A. J., & Bartelink, I. H. (2026). Combining imaging strategies with physiologically-based pharmacokinetic modeling to improve precision dosing & drug delivery in brain tumors. Journal of Controlled Release, 399, 115451. https://doi.org/10.1016/j.jconrel.2026.115451

Vancouver

Jordens T, Elskamp AJ, Bartelink IH. Combining imaging strategies with physiologically-based pharmacokinetic modeling to improve precision dosing & drug delivery in brain tumors. Journal of Controlled Release. 2026;399:115451. doi:10.1016/j.jconrel.2026.115451

BibTeX
@article{Jordens2026,
  author = {Jordens, Tamara and Elskamp, Anne-Jaël and Bartelink, Imke H},
  title = {Combining imaging strategies with physiologically-based pharmacokinetic modeling to improve precision dosing & drug delivery in brain tumors},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {399},
  pages = {115451},
  doi = {10.1016/j.jconrel.2026.115451}
}
Kostenlos starten →